Author:
Zhao Yin,Lyu Xiaoyue,Shen Chun,Fang Yumin
Reference29 articles.
1. The observation of the clinical effect of Bushen Tiaozhou Fahe Shoutai pill in the sequential treatment of 40 pregnant women with polycystic ovary syndrome [in Chinese];Cuiping Li;Journal of Sichuan of Traditional Chinese Medicine,2009
2. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System;K Devine;Fertil. Steril,2015
3. The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response;S Dogan;J. Gynecol. Obstet. Hum. Reprod,2021
4. Expert Group of Consensus on Clinical Diagnosis & Management of Diminished Ovarian Reserve; Reproductive Endocrinology &Fertility Preservation Section of Chinese Society on Fertility Preservation under Chinese Preventive Medicine Association, 2022. Consensus on clinical diagnosis and management of diminished ovarian reserve [in Chinese];Journal of Reproductive Medicine
5. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway;R Garc�a-Escudero;Oral Oncol,2018